UNSPSC 85515807: Occlusion of left posterior tibial artery, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to occlusion of left posterior tibial artery, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 04LS3ZZ

UNSPSC 85515807 Occlusion of left posterior tibial artery, percutaneous approach is a Commodity code that shows little relevant recent activity under its nominal scope. The source identifies this code as a medical procedure classification, yet the state and local contract opportunities tagged with it span occupational medical surveillance, pharmacy benefit management, disability medical evaluations, surgical procedure carve-out networks, temporary health professional staffing, and specialty medical services for youth in detention. None of these solicitations involve the specific vascular intervention the code names. The mismatch suggests either classification error in the opportunities themselves or that this code does not map cleanly to current state and local purchasing activity.

The issuing bodies posting opportunities under this code include state health and transportation agencies (Washington State Department of Transportation), county governments and health systems (Collier County, Santa Clara County Health System, Harris County Juvenile Probation Department), and cities (Phoenix, Long Beach). Geographic distribution spans Arizona, California, Florida, Texas, and Washington. Representative recent opportunities include the Washington State Department of Transportation's occupational medical surveillance RFP due October 9, 2026; the City of Phoenix Retirement Office's independent medical evaluation services RFP due October 16, 2026, valued at $750,000 over five years; and the Collier County Board of County Commissioners' pharmacy benefit management RFP due April 9, 2026, with historical annual pharmacy spending of approximately $8.7 million. The code does not demonstrate coherent procurement activity aligned with its stated commodity definition.